Ischemic heart disease blocks blood
supply to the heart. It is also known as coronary artery disease. Blood
vessels get blocked or narrowed due to cholesterol deposition on the
walls. This decreases nutrients and oxygen supply to heart muscles,
which is important for appropriate functioning of the heart. This
results in a part of the heart being rapidly run down of its blood
supply and causes death of heart tissues. This leads to heart attack.
Report Overview @ https://www.transparencymarketresearch.com/ischemic-heart-disease-treatment-market.html
Heart is a pump that supplies oxygenated
blood to the body or various organs. A less efficient heart directly
disturbs the oxygen supply to the vital organs such as liver, kidney,
and brain. This leads to death of tissues of these organs and eventual
failure. Ischemic heart disease is one of the major causes of death in
various countries. Major risk factors for ischemic heart disease are
cholesterol levels, smoking, and diabetes mellitus. Moreover, persons
with hypercholesterolemia have higher chance to develop the disease.
Hypertension and stress are also major factors for development of
ischemic heart disease. Genetic and hereditary factors are responsible
for the disease.
Symptoms of ischemic heart disease is
visible. These include acute chest pain related to unstable angina,
angina pectoris, myocardial infraction, or acute coronary syndrome.
Other symptoms include heart failure -struggle in breathing due to
weakness of the heart muscle. Many people may have ischemic attacks
without knowing it. People have ischemic attack without pain, known as
silent ischemia. People may have heart attack without prior warning.
People who have angina may also have
undiagnosed episode of silent ischemia. In addition, people with
diabetes or people who had previous heart attacks are at high risk of
developing silent ischemia. Ischemic heart disease can be prevented by
avoiding stress, sedentary lifestyle, smoking, and fatty diet, as these
are the major causes of ischemic heart diseases. Additionally, avoiding
foods with high saturated fats in essential to decrease level of lipid
in the blood stream and to stop arteriosclerosis. Regular exercise is
also important to reduce the risk of ischemic heart disease.
Hypertension and cholesterol should be under control with appropriate
treatment.
Ischemic heart disease is treated with
various drugs such as aspirin, statins, calcium channel blockers, beta
blockers, and organic nitrates. Increasing alcohol consumption &
smoking and unhealthy lifestyle are the major factors fueling the growth
of the ischemic heart disease treatment market. Rising obese and
geriatric population also boosts market growth. However, high treatment
cost and uncertainty in reimbursement are the major restraints of the
ischemic heart disease treatment market.
The global ischemic heart disease
treatment market has been segmented based on treatment, region, and
end-user. In terms of treatment, the market has been classified into
drugs and other treatments. The drugs segment has been sub-segmented
based on drug class into NSAID, statins, calcium channel blockers, beta
blockers, organic nitrates, and others. In terms of region, the global
ischemic heart disease treatment market has been segmented into the
Americas, EMEA, and Asia Pacific. Americas dominated the global market
due to advanced lifestyle, consumption of fatty foods, and high obese
& geriatric population. The market in Asia Pacific is expected to
expand at a high growth rate, driven by rapidly developing economies
such as China and India.
Key market players operating in the
global ischemic heart disease treatment market are Abbott Vascular,
Terumo Corporation, Medtronic, and Boston Scientific Corporation, among
others.
No comments:
Post a Comment